Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Buy Us a Coffee
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2020-25174
Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
B. Braun OnlineSuite
Source: NVD (National Vulnerability Database)
Vulnerability Description
A DLL hijacking vulnerability in the B. Braun OnlineSuite Version AP 3.0 and earlier allows local attackers to execute code on the system as a high privileged user.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
对搜索路径元素未加控制
Source: NVD (National Vulnerability Database)
Vulnerability Title
B. Braun Melsungen AG OnlineSuite AP 代码问题漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
B. Braun Melsungen AG onlinesuite是德国贝朗（B. Braun Melsungen AG）公司的一款应用于医疗的数字化管理平台。 B. Braun OnlineSuite AP 3.0 及之前版本存在代码问题漏洞，该漏洞允许本地攻击者以高特权用户的身份在系统上执行代码。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
B. Braun Melsungen AGOnlineSuite AP ~ 3.0 -
II. Public POCs for CVE-2020-25174
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2020-25174
Please Login to view more intelligence information
IV. Related Vulnerabilities
Same product: OnlineSuite
Same vendor: B. Braun Melsungen AG
Same weakness: CWE-427
V. Comments for CVE-2020-25174

No comments yet

Leave a comment